Immunovant Stock (NASDAQ: IMVT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 174.000 / 1.264M |
Day Range | - - - |
52 Wk Range | 14.050 - 45.580 |
Market Cap | $4.758B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 12.89% |
Days to Cover | 7.79 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immunovant (NASDAQ: IMVT) through any online brokerage.
Other companies in Immunovant’s space includes: Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS), Alkermes (NASDAQ:ALKS), SpringWorks Therapeutics (NASDAQ:SWTX) and Vaxcyte (NASDAQ:PCVX).
The latest price target for Immunovant (NASDAQ: IMVT) was reported by Truist Securities on Monday, March 25, 2024. The analyst firm set a price target for 48.00 expecting IMVT to rise to within 12 months (a possible 46.56% upside). 36 analyst firms have reported ratings in the last year.
The stock price for Immunovant (NASDAQ: IMVT) is $32.75 last updated March 27, 2024 at 5:01 PM EDT.
There are no upcoming dividends for Immunovant.
Immunovant’s Q4 earnings are confirmed for Monday, May 20, 2024.
There is no upcoming split for Immunovant.
Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.